✦ LIBER ✦

PO125 INFLUENCE OF HER2 STATUS ON METASTATIC PATTERN IN POSTMENOPAUSAL HORMONE RECEPTOR POSITIVE BREAST CANCER PATIENTS TREATED WITH ADJUVANT TAMOXIFEN ONLY

✍ Scribed by Spasojevic, Ivana Bozovic; Susnjar, Snezana; Kovacevic, Marijana Milovic; Konstatinovic, Zora Neskovic; Vujasinovic, Tijana; Aburabi, Zaki; Milovanovic, Zorka; Gavrilovic, Dusica

Book ID: 122177189
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 53 KB
Volume: 22
Category: Article
ISSN: 0960-9776
DOI: 10.1016/S0960-9776(13)70138-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ki-67 evaluation at the hottest spot pre

Ki-67 evaluation at the hottest spot predicts clinical outcome of patients with hormone receptor-positive/HER2-negative breast cancer treated with adjuvant tamoxifen monotherapy

✍ Honma, Naoko; Horii, Rie; Iwase, Takuji; Saji, Shigehira; Younes, Mamoun; Ito, Y 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 383 KB

PO124 THE INFLUENCE OF HER2 STATUS ON LO

PO124 THE INFLUENCE OF HER2 STATUS ON LOCALIZATION OF THE FIRST RELAPSE SITE IN YOUNG HR-POSITIVE BREAST CANCER PATIENTS TREATED WITH ADJUVANT OVARIAN ABLATION

✍ Milovic-Kovacevic, Marijana; Susnjar, Snezana; Bozovic-Spasojevic, Ivana; Neskov 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 53 KB

156 Positive HER2 status – Is it a discr

156 Positive HER2 status – Is it a discriminating factor for disease outcome in steroid receptor-positive early breast cancer patients treated with adjuvant endocrine therapy only?

✍ S. Susnjar; T. Vujasinovic; Z. Abu Rabi; Z. Neskovic-Konstantinovic; Z. Milovano 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Hormone Receptor Status and TN Stage Inf

Hormone Receptor Status and TN Stage Influence the Locoregional Benefit From Trastuzumab in Patients With HER 2–Positive Breast Cancer After Adjuvant Radiation Therapy

✍ Cao, L.; Cai, G.; Yu, X.; Ma, J.; Yang, Z.; Shao, Z.; Guo, X.; Chen, J. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 72 KB

0054 Tumor size rather than c-erbB-2 gen

0054 Tumor size rather than c-erbB-2 gene amplification significantly influence the disease outcome in postmenopausal steroid receptor-positive breast cancer patients treated with adjuvant tamoxifen

✍ S. Susnjar; T. Vujasinovic; Z. Abu Rabi; D. Gavrilovic; Z. Neskovic-Konstantinov 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Anastrozole Plus Trastuzumab Prolongs Pr

Anastrozole Plus Trastuzumab Prolongs Progression-Free Survival in Postmenopausal Patients with HER2-Positive and Hormone Receptor–Positive Metastatic Breast Cancer: A Review of the TAnDEM Study

✍ Basi, Sanraj K.; Mackey, John R. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 59 KB